Moderna will put together materials and conduct scientific trials to gather safety and immunogenicity info to help FDA licensure and potential professional scale-up in response to a foreseeable future PHE. This award will enable the immediate progress of an mRNA vaccine targeted to varied influenza virus subtypes, also called strains, https://www.amazon.in/gp/product/B0DCVQNHKT